BBS2 and Bardet-Biedl syndrome: The distribution of pathogenic variants in our BBS cohort was similar to other recent studies from Europe and the USA with a predominance of pathogenic variations in BBS1 and BBS10 [9–11], but differed from a study in China, where the majority of patients were affected by mutations in BBS2 and BBS7 [42].